ABSTRACT

Historically, the relationship between patents and medicines has been controversial. The incorporation, in 1994, of intellectual property in the multilateral trading system and the implications for public health issues has attracted intense public attention. This chapter examines the context and background to the current debate, particularly the implementation of the Doha Declaration on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health.